
FDA OKs First-Line Immunotherapy Combo for Mesothelioma
- Wellness
- Admin COUPONS
- October 5, 2020
(MedPage Today) — The FDA on Friday approved dual checkpoint blockade with nivolumab (Opdivo) plus ipilimumab (Yervoy) for the first-line treatment of unresectable malignant pleural mesothelioma.
Support for the approval was based on findings…
%%item_READ_MORE…_button%%